Skip to main content
. 2015 Dec 8;10(12):e0143896. doi: 10.1371/journal.pone.0143896

Fig 3. Caspase 3 activity in patients with VWD-type 2B.

Fig 3

Washed platelets (2.5 x108 platelets/mL) pretreated or not with ABT-737 (10 μM) were lysed and caspase-3 activity was assessed by immunoblotting with A) an anti-caspase-3 antibody B) with an anti-gelsolin antibody and C) with anti-calpain 1 antibody. Results are representative of two or three independent experiments.